1 / 4

【 第 2 回世界薬学会議 】 テーマ:「先端治療を担う医薬品開発に向けた科学の地球的展開」 会 期: 2004 年 5 月 29 日(土)~ 6 月 3 日(木) - PowerPoint PPT Presentation

  • Uploaded on

【 第 2 回世界薬学会議 】 テーマ:「先端治療を担う医薬品開発に向けた科学の地球的展開」 会 期: 2004 年 5 月 29 日(土)~ 6 月 3 日(木) 会 場:国立京都国際会館(京都市左京区宝ヶ池). Organizing Committee. Chair: 杉山 雄一(日本) Program Co-Chairs: 橋田 充(日本) Vincent H.L. Lee (アメリカ) Hans E. Junginger (オランダ) Fund-raising Co-Chairs: 寺田 弘(日本) Gordon L. Amidon (アメリカ)

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' 【 第 2 回世界薬学会議 】 テーマ:「先端治療を担う医薬品開発に向けた科学の地球的展開」 会 期: 2004 年 5 月 29 日(土)~ 6 月 3 日(木)' - reyna

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript



会 期:2004年5月29日(土)~6月3日(木)

会 場:国立京都国際会館(京都市左京区宝ヶ池)

Organizing Committee

Chair: 杉山 雄一(日本)

Program Co-Chairs: 橋田 充(日本)

Vincent H.L. Lee(アメリカ)

Hans E. Junginger(オランダ)

Fund-raising Co-Chairs: 寺田 弘(日本)

Gordon L. Amidon(アメリカ)

Malcolm Rowland(英国)

Publicity Co-Chairs: 本多 利雄(日本)

Kamal K. Midha(カナダ)

Claus-Michael Lehr(ドイツ)

Scientific Advisory Committee

Co-Chairs: 永井 恒司(日本)

Leslie Z. Benet(アメリカ)

FIP Head Office

General Secretary: Ton Hoek

Congress Manager FIP: Gretie R.v.d. Baumen


American Association of Pharmaceutical Scientists (AAPS)

Association de Pharmacie Galenique Industrielle (APGI)

Academy of Pharmaceutical Sciences of Great Britain (APSGB)

Academy of Pharmaceutical Science and Technology, Japan (APSTJ)

Controlled Release Society (CRS)

European Federation for Pharmaceutical Sciences (EUFEPS)

Pharmaceutical Society of Japan (PSJ)


第2回世界薬学会議 (PSWC2004) 事務局

〒113-0033 東京都文京区本郷4-2-8 フローラビル7F


TEL: 03-3815-1681FAX: 03-3815-1691

E-mail: [email protected]

Website: http://edpex104.bcasj.or.jp/pswc2004/

Provisional Symposia Titles (35)

1. Proteomics in Drug Discovery and Design: Analytical Aspects


2. New Mass Spectrometric Methodologies in Drug Development


3. Microchip-based Analytical Systems


4. Drug Metabolism and Transport Studies in the Drug Discovery and Development


5. Drug Interactions on Drug Metabolism and Drug Transport


6. Interplay Between Drug Metabolizing Enzymes and Transporters


7. Regulation of Gene Expression of Drug Metabolizing Enzymes and Transporters


8. Receptors and Ion Channels as Targets for Drug Development


9. Signal Transduction: New Concepts and Trends


10. Growth Factors: Receptors and Beyond


11. New Strategies for Mucosal Drug Delivery: Bioadhesion, Particulate Carriers, etc.


12. Intelligent Biomaterials and Microprocessor Control in Drug Delivery


13. Nanotechnologies in Gene and Vaccine Delivery


14. From Hit-to-Candidate: Optimizing Lead Development and Timelines in Medicinal



15. Synthesis and Chemical Modification of Drugs and Bioactive Natural Products: New



16. Natural Products and Traditional Medicines: Isolation, Structure Determination,

Biosynthesis, Engineered Biosynthesis, and Clinical Exploitation


17. Technical and Regulatory Challenges of Using Transgenic Plants and Animals to Produce Protein Therapeutics


18. DNA as a Drug: Recent Advances in Gene Therapy


19. Recent Advances in Stem Cell Therapy for Human Disease


20. Challenges in Oral Delivery of Drugs with Inherent Difficulties for Absorption


21. New Technologies for Protein Delivery Systems


22. Computer-aided Formulation Design and Optimization


23. Drug Target Validation: A Key Step in Drug Discovery


24. Bioinformatics in Drug Discovery


25. Structural Genomics; The Next Step


26. Prion Diseases in Animals and Human


27. Genetic Issues on BA/BE Studies for Oral Drug Products


28. Evaluation and Prediction of BA/BE for Oral Drug Products: Design and Criteria


29. PK/PD Modeling in Drug Therapies: Conventional and Population PK/PD Modeling


30. Tailor-made Drug Therapy: Genotyping and Phenotyping


31. Translational Research for Incurable Diseases


32. Therapeutic Drug Monitoring: Variability in Drug Response


33. Prospective and Retrospective Strategies for Bridging Studies


34. Current and Future Uses of Toxicogenomics: Regulatory Aspects


35. Exposure-response Relationship: Mechanism-based PK-PD and the Associated Models

and Simulation